MicroRNA profiling in the serums of SCA3/MJD patients

International Journal of Neuroscience

Volumn 124, Issue 2, 2014, Pages 97-101

  Shi, Yuting ^a   Huang, Fengzhen ^a   Tang, Beisha ^a,b   Li, Jiada ^b   Wang, Junling ^a   Shen, Lu ^a,b   Xia, Kun ^b   Jiang, Hong ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

ATXN3 gene; Biomarkers; MiRNAs profiling; Serum; Spinocerebellar ataxia type 3 Machado Joseph disease

Indexed keywords

ATAXIN 3; BIOLOGICAL MARKER; MICRORNA; MICRORNA 125B; MICRORNA 29A; MICRORNA 34B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE EXPRESSION PROFILING; HUMAN; MACHADO JOSEPH DISEASE; PATHOGENESIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; VALIDATION PROCESS; YOUNG ADULT; BLOOD; CASE CONTROL STUDY; DISEASE COURSE; DNA MICROARRAY; GENETICS; MIDDLE AGED;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; HUMANS; MACHADO-JOSEPH DISEASE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; YOUNG ADULT;

EID: 84892383248     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2013.827679     Document Type: Article

References (23)

1. Wang J, Shen L, Lei L, et al. Spinocerebellar ataxias in mainland China: An updated genetic analysis among a large cohort of familial and sporadic cases. Journal of Central South University Medical Sciences 2011;36:482-9
2. Durr A. Autosomal dominant cerebellar ataxias: Polyglutamine expansions and beyond. Lancet Neurol 2010;9: 885-94
3. Bettencourt C, Lima M. Machado-Joseph Disease: From first descriptions to new perspectives. Orphanet J Rare Dis 2011;6:35
4. Gaughwin PM, Ciesla M, Lahiri N, et al. Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum Mol Genet 2011;20:2225-37
5. Hebert SS, Horre K, Nicolai L, et al. MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis 2009;33:422-8
6. Lee Y, Samaco RC, Gatchel JR, et al. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci 2008;11:1137-9
7. Carthew RW, Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009;136:642-55
8. Bartel DP.MicroRNAs: Target recognition and regulatory functions. Cell 2009;136:215-33
9. Aumiller V, Forstemann K. Roles of microRNAs beyond development- metabolism and neural plasticity. Biochim Biophys Acta 2008;1779:692-6
10. Carissimi C, Fulci V, Macino G. MicroRNAs: Novel regulators of immunity. Autoimmun Rev 2009;8:520-4
11. Aw S, Cohen SM. Time is of the essence: MicroRNAs and ageassociated neurodegeneration. Cell Res 2012;22:1218-20
12. Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010;127:118-26
13. Cogswell JP, Ward J, Taylor IA, et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 2008;14:27-41
14. Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PloS One 2008;3:e3148
15. Sevcikova S, Kubiczkova L, Sedlarikova L, et al. Serum miR-29a as a marker of multiple myeloma. Leuk Lymphoma 2013; 54:189-91
16. Schmidt MT, Handschuh L, Zyprych J, et al. Impact of DNA microarray data transformation on gene expression analysis-comparison of two normalization methods. Acta Biochim Pol 2011;58:573-80
17. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8
18. Pogue AI, Cui JG, Li YY, et al. Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci Lett 2010;476:18-22
19. Roshan R, Ghosh T, Gadgil M, Pillai B. Regulation of BACE1 by miR-29a/b in a cellular model of Spinocerebellar ataxia 17. RNA Biol 2012;9:891-9
20. Shioya M, Obayashi S, Tabunoki H, et al. Aberrant microRNA expression in the brains of neurodegenerative diseases: MiR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol Appl Neurobiol 2010;36:320-30
21. Cheever A, Blackwell E, Ceman S. Fragile X protein family member FXR1P is regulated by microRNAs. RNA 2010;16:1530-9
22. Fang C, Zhu DX, Dong HJ, et al. Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma. Ann Hematol 2012;91:553-9
23. Scholer N, Langer C, Dohner H, et al. Serum microRNAs as a novel class of biomarkers: A comprehensive review of the literature. Exp Hematol 2010;38:1126-30